Sana Health raises $5.8M to get through clinical trials

August 4, 2020

Sana Health Inc. raised $5.8 million in new venture funds as it prepares to close out two trials for treating pain.

According to filings with the U.S. Securities and Exchange Commission, the Lafayette company raised the round through a sale of preferred stock and convertible notes to 44 investors. The company’s goal for the round is $9 million.

The fundraiser comes a day after Sana announced that the U.S. Food and Drug Administration approved the company’s product for sale as a “general wellness” device.

Full article here.